Novo Nordisk is providing direct-to-patient delivery of Wegovy ... FDA-approved Wegovy at a reduced cost in our high-quality pen.” For eligible patients, health care providers can send Wegovy ...

Novo Nordisk said it will offer all doses of Wegovy for $499 a month to patients paying cash, a bid to reach consumers who ...

NovoCare Pharmacy will provide all dose strengths of Wegovy at a reduced cost of $499 per month for cash-paying patients ...

The weight-loss drug can cost patients more than $1,000 a month if they do not have health insurance coverage.

Novo Nordisk is introducing a direct-to-patient delivery option for its flagship weight loss drug Wegovy (semaglutide), ...

After Zepbound-maker Eli Lilly reduced the price of the weight-loss drug, competitor Novo Nordisk has cut the price of weight ...

Novo Nordisk is expanding its reach in the obesity ... NovoCare will supply all dosage strengths of Wegovy in single-dose injection pens that will be shipped directly to a patient’s home.

Novo Nordisk announced a new cash-pay option for its blockbuster weight-loss drug Wegovy, offering a monthly dose at $499 and home delivery. The move follows competitor Eli Lilly ...

Against a backdrop of manufacturing prioritisation, Novo Nordisk’s contract with Swiss medical technology Ypsomed could include the supply of injection pens for CagriSema, the former’s ...

Novo Nordisk is providing direct-to-patient delivery ... FDA-approved Wegovy at a reduced cost in our high-quality pen.” For eligible patients, health care providers can send Wegovy ...